U.S. market Closed. Opens in 17 hours 13 minutes

RCUS | Arcus Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue117.00M112.00M382.88M77.52M15.00M8.35M1.41MN/A
Cost of Revenue16.00M14.00M7.06M159.00M78.48MN/AN/AN/A
Gross Profit101.00M98.00M375.82M-81.48M-63.48M8.35MN/AN/A
Operating Expenses457.00M392.00M328.63M201.75M103.71M63.21M54.85MN/A
Selling, General & Admin117.00M104.00M72.29M42.40M25.23M13.57M7.64M3.94M
Research & Development340.00M288.00M256.35M159.35M78.48M49.65M47.22M14.25M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-340.00M-280.00M54.25M-124.23M-88.71M-54.86M-53.44M-18.18M
Other Expenses / Income39.00M14.00M397.00K1.38M4.00M343.00K359.00K212.00K
Before Tax Income-301.00M-266.00M54.65M-122.86M-84.71M-49.59M-53.08M-17.97M
Income Tax Expenses6.00M1.00M1.81M-6.18M-8.78M5.26MN/AN/A
Net Income-307.00M-267.00M53.00M-116.68M-75.93M-49.59M-53.08M-17.97M
Interest Expenses2.00M2.00M260.00KN/AN/A4.92MN/AN/A
Basic Shares Outstanding74.00M72.00M69.35M54.79M43.83M34.62M24.55M24.55M
Diluted Shares Outstanding74.00M72.00M73.97M54.79M43.83M34.62M24.55M24.55M
EBITDA-291.00M-264.00M54.91M-124.85M-88.71M-56.09M-50.47M-16.87M
EBITDA Margin-248.72%-235.71%14.34%-161.06%-591.39%-671.47%-3,571.83%0.00%
EBIT-299.00M-264.00M55.08M-122.86M-84.71M-39.41M-53.08M-17.97M
EBIT Margin-255.56%-235.71%14.38%-158.49%-564.73%-471.77%-3,756.69%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙